See the article here: Immix Biopharma Subsidiary Nexcella Appoints Jeffrey H. Cooper, former Chief Financial Officer of BioMarin, to Board of Directors
See the article here: Immix Biopharma Subsidiary Nexcella Appoints Jeffrey H. Cooper, former Chief Financial Officer of BioMarin, to Board of Directors
Here is the original post: Nexcella Appoints Jeffrey H. Cooper, former Chief Financial Officer of BioMarin, to Board of Directors
Read more from the original source: Cidara Therapeutics to Present Ongoing Development of Drug-Fc Conjugates (DFC) Including CD73-Targeting DFC From Its Cloudbreak® Platform at...
Original post: IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2023
Link: Sanofi: Information concerning the total number of voting rights and shares - May 2023
See the original post here: ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit
View post: FBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)
View original post here: Biomea Fusion to Present Late Breaking Data from Ongoing Phase II Trial, COVALENT-111, Evaluating BMF-219 in Patients with Type 2 Diabetes at ADA 2023
Read the original post: BioCardia Announces FDA Completes Review of Proposed Adaptive Statistical Analysis Design for Ongoing CardiAMP Cell Therapy in Heart Failure Pivotal...
Visit link: Bioasis Provides Corporate Update and Announces Suspension of Operations
Recent Comments